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ABSTRACT 
 
A new family of water-borne, biocompatible and carboxyl-
functionalized nanogels was developed for glutathione-
mediated delivery of anticancer drugs. Poly(N-vinyl-
pyrrolidone)-co-acrylic acid nanogels were generated by e-
beam irradiation of aqueous solutions of a crosslinkable 
polymer, using industrial-type linear accelerators and set-
ups. Nanogels physico-chemical properties and colloidal 
stability, in a wide pH range, were investigated. In vitro cell 
studies proved that the nanogels are fully biocompatible 
and able to quantitatively bypass cellular membrane. An 
anticancer drug, doxorubicin (DOX), was linked to the 
carboxyl groups of NGs through a spacer containing a 
disulphide cleavable linkage. In vitro release studies 
showed that glutathione is able to trigger the release of 
DOX through the reduction of the S-S linkage at a 
concentration comparable to its levels in the cytosol. 
 
Keywords: nanogels, e-beam radiation, disulphide 
linkage, doxorubicin. 
 
Introduction 
The efficacy of a cancer therapeutic drug is measured by its 
ability to reduce and eliminate tumors without damaging 
healthy tissue. However, anticancer drugs suffer some 
limitations related to their poor solubility in aqueous 
environment, non-specificity in their distribution through 
the body compartments and severe adverse side effects. 
Furthermore, during the prolonged treatment with 
chemotherapeutic drugs, tumor cells develop multidrug 
resistance (MDR) and the drugs effectiveness decreases 
over time [1]. Cancer-fighting therapeutic devices based on 
nanoparticle systems offer the possibility of overcoming the 
problems mentioned above. In fact, nanocarriers are able to 
increase the solubility of hydrophobic drugs, decrease the 
toxicity toward healthy cells and escape from multi-drug 
resistance bypassing the efflux pumps and increase the drug 
intracellular concentration. Nanoparticles can be formulated 
with appropriate size, shape, surface properties and specific 
chemical functionality for covalent coupling of targeting 
moieties. Because of these tunable physico-chemical 
properties, nanoparticles may combine active and passive 
targeting in one single platform. Upon nanoparticle devices 
reach the target cells, they should be able to release the 
drug. Stimulus-mediated release is receiving great attention 
for intracellular drug delivery and various stimuli-
responsive nanoparticles have been developed and 
investigated extensively, including temperature, pH, ultra 
sound, redox, and enzyme responsive ones [2]. Doxorubicin 
is one of the most effective chemotherapeutic anticancer 
drugs and it is crucial for the treatment of a wide range of 
tumors as breast cancer, acute leukemia and malignant 
lymphoma [3]. We have developed a new family of water-
borne, biocompatible and carboxyl-functionalized nanogels 
(NGs) for glutathione-mediated delivery of Doxorubicin. In 
our approach, DOX is linked to nanoparticles through a 
linker containing a cleavable disulphide bridge, 
aminoethyldithiopropionic acid (AEDP). The release 
mechanism is based on the existence of a large difference in 
the redox potential between the mildly oxidizing 
extracellular milieu and the reducing intracellular fluids. 
The reducing agent is glutathione (GSH) that is found in the 
blood plasma of humans with micromolar concentrations, 
whereas it is around 10 mM in the cytosol. The 
concentration level of cytosolic GSH in cells with an 
enhanced level of oxidative stress, as in tumor cells, is 
several times higher than that in normal cells [2]. In 
alternative to more conventional synthetic approaches, 
which often imply several reactive and purification steps, a 
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robust and economically viable manufacturing process was 
developed for the production of nanogels. Nanogels were 
generated by e-beam irradiation of semi-dilute aqueous 
solutions of a crosslinkable polymer and acrylic acid, using 
industrial-type linear accelerators and irradiation conditions 
typically applied for sterilization purposes in industry, by 
irradiating at relatively low dose per pulse, high frequency 
and 40 kGy of integrated dose [4-6]. In particular, poly(N-
vinyl-pyrrolidone)-co-acrylic acid (PVP-co-AA) variants 
with controlled size and surface charge density, high 
colloidal stability in a wide pH range (5 - 10) and multi-
arms with terminal functional groups available for further 
conjugation, were generated quantitatively and 
reproducibly. Physico-chemical properties and colloidal 
stability of the generated nanoparticles were investigated 
through DLS techniques and ζ-potential measurements. In 
vitro cell studies proved that the nanogels are fully 
biocompatible and able to quantitatively bypass cellular 
membrane. In vitro release experiments showed that GSH is 
able to trigger the release of DOX through reduction of the 
disulphide linkage at concentrations comparable to its 
levels in cytosol. 
Experimentals 
Materials 
PVP k60, acrylic acid (AA), amino-fluorescein (AF),1-
ethyl-3-(3 dimethylaminopropyl) carbodiimide (EDC), and 
2-(N-morpholino)ethanesulfonic acid (MES), glutathione 
(GSH), doxorubicin (DOX) were supplied by Aldrich. 
AEDP was supplied by VWR. 
Methods 
Preparation of PVP-co-AA NGs: PVP aqueous solutions at 
a concentration of 0.5 wt% in presence of acrylic acid 
(molar ratio between PVP repetitive unit and acrylic acid 
equal to 50) were prepared by overnight stirring, filtered 
with 0.22 µm pore size syringe filters, carefully 
deoxygenated with gaseous nitrogen and individually 
saturated with N2O (N2O ≥99.99%) prior to irradiation. 
Electron beam irradiation was performed using a 10 MeV 
linear accelerator at the ICHTJ of Warsaw (Poland). An 
integrated dose of 40 kGy was supplied. After irradiation 
samples were dialyzed (MWCO 100K Da) against distilled 
water for 48 h to remove eventual unreacted monomer, 
oligomers and low MW polymer. The yield of recovered 
nanogels after dialysis was determined gravimetrically. 
Hydrodynamic diameters (Dh) of NGs dispersions were 
measured by dynamic light scattering (DLS) using 
Brookhaven BI-9000 correlator and a 50 mW He−Ne laser 
(MellesGriot) tuned at λ = 632.8 nm. Particles size 
distributions expressed as volume % and the mean 
hydrodynamic diameter and PDI determined by the 
cumulant method are reported [8]. Surface charge density 
of NGs in water was measured at 25°C using a 
ZetaSizerNano ZS (Malvern Instruments Ltd, Malvern, 
UK) equipped with a He-Ne laser at a power of 4.0 mW. 
Mean ζ-potential values and the relative width of the 
distribution were reported for each sample. Both DLS and 
ζ-potential measurements were carried on 1 mg/ml 
dispersions at 20°C in water solutions of different pHs and 
controlled ionic strength (IS=1mM).  
Cytotoxicity of nanoparticles on vein endothelial cell 
(ECV304) was assessed by MTT assay (Sigma). Cells were 
seeded in a 96-well plates at density of 1 × 104 cell/well, in 
complete medium MEM199. After 24 hr from seeding, cells 
were exposed to particle suspension at different 
concentrations (30 µg/ml, 60 µg/ml, 120 µg/ml), for 24 hr at 
37°C. Not treated ECV304 cells were used as negative 
control and those treated with DOX [5 µM] for 24 hr were 
used as positive control. The % of cell viability was 
calculated as ratio between each sample with respect to the 
negative control (100% of viability).  
Localization studies were performed on ECV 304 cells. 
ECV 304 were grown at a density of 5 × 103 cells/well into 
12-well plates containing sterile glass coverslips in 
complete medium MEM199 for 24 hr. Next, the cells were 
incubated with 120 µg/ml of NGs, which emit green 
fluorescence by aminoflorescein conjugation. After 
different incubation times, 1 hr, 3 hr, 6 hr and 24 hr 
respectively, cells were extensively washed with PBS, to 
remove not reactive nanoparticles, and fixed with 3.7% 
formaldehyde for 15 minutes; then were again washed with 
PBS. Subsequently, the cells were stained with EtBr 
(1:1000) for 1 minute at room temperature. Localization 
was carried out by confocal microscopy analyzer (Olympus 
1x70 with Melles Griot laser system). 
Preparation of AEDP-DOX-P*(0.5)AA50 NGs: NGs were 
conjugated with AEDP and DOX by a two steps process. A 
standard EDC/Sulfo-NHS based protocol was adapted to 
our systems [7]. Both steps were carried out at 25°C , in pH 
5 MES buffer, in excess of ligands with respect to the 
carboxyl groups and under continuous stirring. AEDP-
DOX-P*(0.5)AA50 NGs were then purified through 
prolonged dialysis against water. 
Reduction-Triggered DOX release:! DOX-AEDP-
P*(0.5)AA50 NGs were placed into a dialysis tubing 
(MWCO 12 kDa) with 10 mM of GSH or without, as 
control, and immersed in 20 ml of PBS (pH 7.4). The 
systems were kept at 37°C under shaking (200 rpm). At 
predetermined time intervals (1, 2, 4, 6, 8, 12, 24 hr), 1 ml 
of external buffer solutions were withdrawn and replaced 
with 1 ml of fresh PBS. 
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Figure 1. Particles size distributions in water at different pH obtained by DLS measurements. In inset table, the mean 
hydrodynamic diameter and PDI for each distribution shown and mean ζ-potential and relative width for each system are 
reported.
The amount of DOX linked to NGs and the amount 
released were determined by fluorescence measurements 
(λecc 480 nm, λem 550 nm) using a Jasco 6500 
spectrofluorimeter. 
Results and discussion 
Water borne PVP-co-AA NGs were generated through e-
beam irradiation, starting from a semi-diluted polymer 
aqueous solution in presence of acrylic acid. The yield of 
process was about 90% [9]. Nanogels variants with 
different particles size, surface properties and degree of 
functionalization were obtained [9]. In this work only a 
brief description of the basic physico-chemical properties of 
the system selected for the conjugation with AEDP and 
DOX is reported. Size, surface properties and colloidal 
stability in a wide pH range (5-10) are very important 
parameters for intracellular delivery of nanoparticles and 
were investigated through DLS measurements and ζ-
potentials determinations. As shown in Figure 1, the 
particle size distributions of P*(0.5)AA50 NGs in water 
solution of different pHs and equal ionic strength (IS=1 
mM) display a monomodal distributions for all the systems, 
with an average diameter varying from 35 nm to 26 nm and 
low PDI values (0.23-0.3). The hydrodynamic diameter is 
fairly invariant in a wide pH range (5-10), only at pH 3.5, it 
is slightly bigger due to the onset of aggregation 
phenomena, which become faster at pH<3.5. At this pH, 
below the pKa of acrylic acid (pKa=4.75), a great 
proportion of carboxyl groups present on nanogels multi-
arms becomes protonated, thus ζ-potential value is about 0 
mV. At pH>3.5, the ζ-potential values become negative and 
their absolute values increase with the pH due to 
progressive dissociation of carboxyl groups. Since carboxyl 
groups are preferentially located on the “multi-branched 
arms” of NGs, their degree of dissociation does not affect 
the NGs’ hydrodynamic size. Carboxyl groups located on 
NGs arms are easily accessible to covalent conjugation with 
fluorescent probes, small peptides, such as folic acid, and 
oligonucleotides. The availability, different positions and 
accessibility of functional groups on NGs allow performing 
multiple conjugations on the same nanoparticles (data here 
not shown for brevity). The chemical structure of the 
produced NGs was characterized through different 
spectroscopic techniques and it closely resembles that of the 
linear PVP [9]. P*(0.5)AA50 NGs were thought as devices 
for therapeutically purposes, therefore it is necessary to 
check on their biocompatibility by in vitro assays before 
proposing them for any biomedical application. The 
biocompatibility of P*(0.5)AA50 NGs was evaluated using 
MTT viability assay. The Figure 2 shows the relative 
viability of ECV304 cells after 24 hr of incubation with 
NGs dispersions at different concentrations. It is evident 
that, in the presence of NGs, cells viability is similar to that 
of the negative control (untreated cells). Differently, DOX-
treated cells (positive control) show a lower cells viability. 
P*(0.5)AA50 NGs are not cytotoxic. 
  
Figure 2. Evaluation of cell viability using MTT analysis.  
NGs movements through the cell membrane and their 
internalization was investigated by confocal microscope 
analysis using a fluorescent variant of P*(0.5)AA50 NGs. 
We analyzed nanogels distribution in cell compartments at 
different times. As shown in Figure 3, after 1 (A) and 3 hr 
(B) of incubation, the amount of nanoparticles internalized 
slowly increases; whereas, after 6 hr (C) the nanogels are 
cytoplasmatic compartmentalized in the perinuclear area. 
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After 24 hr (D) nanogels concentration inside cells 
decreases, probably due to excretion as waste products in 
the extracellular environment. NGs showed a good affinity 
for cells, as they rapidly and quantitatively bypass the 
cellular membranes, being then released from the cells. 
P*(0.5) AA50 NGs were conjugated with AEDP and DOX 
through a two steps conjugation procedure. The choice to 
link the drug by a spacer with a cleavable linkage, over the 
physical encapsulation or the direct bond to NGs, was 
driven by the need to achieve a great control of drug release 
at the target site. Upon reaching the target tumor cells, the 
“drug” conjugated NGs should be internalized by cells and 
the release triggered by the stimulus. For DOX-AEDP-
P*(0.5)AA50 NGs the stimulus is a redox agent, 
glutathione. 
 
Figure 3. Localization assay by confocal microscopy 
analysis of a fluorescent variant of P*(0.5)AA50 NGs, 
incubated on ECV304 cell respectively for: A. 1 hr; B. 3 hr; 
C. 6 hr and D. 24 hr. Cell were stained with Ethidium 
Bromide. (Red) Magnification 40X; bar 10 mm. 
 
Figure 4. In vitro release of DOX from DOX-AEDP-
P*(0.5)AA50 NGs in PBS (pH 7.4) at 37 °C with or 
without GSH. 
 
The responsiveness of redox-sensitive NGs conjugated with 
AEDP and Doxo to the GSH stimulus was studied in vitro. 
The drug release studies were performed with 10 mM of 
GSH or without, as negative control. The amount of DOX 
released was quantified through fluorescence 
measurements. The release profiles for both systems are 
shown in Figure 4. The % of DOX release is reported as the 
molar ratio between the DOX released at the time t and the 
DOX linked to nanoparticles at the time t=0 hr. The total 
amount of DOX linked to the nanogels, after the 
purification step, was determined through fluorescence 
measurements. It can be observed that both systems release 
the DOX, but in the presence of GSH the amount of DOX 
released is substantially higher, about 70% vs. 34%, and the 
release is faster. No burst effects are evident. In absence of 
GSH, it is likely released the DOX which is not covalent 
linked to the nanoparticles. In fact, due to its 
hydrophobicity this molecule can be favorably hosted in the 
nanogels interiors. In vitro drug release tests demonstrate 
that the disulphide bridge can be broken under a reductive 
molecule stimulus, such as the GSH. These results 
prompted us to evaluate their performance into biological 
systems. 
 
Conclusions 
 
A new type of redox-responsive NGs was synthetized. The 
synthetic approach developed ensures the quantitative 
production of functionalized nanogels with tailored size and 
surface properties. Nanogels show high colloidal stability, 
biocompatibility, ability to bypass cell membranes and 
preferentially accumulate near the nuclei within 6 hr, being 
then progressively released by cells. The carboxyl groups 
located on the nanogels multi-branched arms can be used 
for further conjugation to generate DOX-AEDP-
P*(0.5)AA50 redox-responsive NG variants. In vitro 
release studies showed that glutathione is able to trigger the 
release of DOX through reduction of the AEDP’s S-S 
linkage at a concentration comparable to its levels in 
cytosol (10 mM). The combination of a single-step, robust 
and economically viable manufacturing process with all the 
favorable properties of the produced NGs make these 
nanoparticles very interesting candidates as smart 
nanocarriers of drugs at specific tumor sites. Studies on the 
GSH mediated intracellular drug release against cells are on 
going. 
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